SB-1295
SB-1295 is an orally active CDK9/T1 inhibitor (IC50=0.17 μM) . SB-1295 shows antiproliferative activity in HCT 116 and MIA PaCa-2 cells. SB-1295 also induces MIA PaCa-2 cell death by inducing intracellular ROS production, reducing mitochondrial membrane potential and inducing apoptosis. SB-1295 has the potential to study cancer[1].
Product Specifications
UNSPSC
12352005
Target
Apoptosis; CDK; Reactive Oxygen Species (ROS)
Type
Reference compound
Related Pathways
Apoptosis; Cell Cycle/DNA Damage; Immunology/Inflammation; Metabolic Enzyme/Protease; NF-κB
Applications
Cancer-Kinase/protease
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/sb-1295.html
Solubility
10 mM in DMSO
Smiles
OC1=C2C(OC(/C=C/C3=CC=CC=C3Cl)=CC2=O)=C([C@]4([H])[C@H](O)C[N+](C)([O-])CC4)C(O)=C1
Molecular Formula
C23H22ClNO6
Molecular Weight
443.88
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog
![NR2C2 Mouse Monoclonal Antibody [Clone ID: OTI1E1]](https://cdn.genprice.uk/products/937/68dd18b9061270361e908031/imageurl/cf807246.webp)
Anti-PIP2;1, PIP2;2, PIP2;3 | Plasma membrane intrinistic protein 2-1, 2-2, 2-3
